Comprehensive analysis of the genome transcriptome and proteome landscapes of three tumor cell lines

Genome Medicine

Volumn 4, Issue 11, 2012, Pages

  Akan, Pelin ^a   Alexeyenko, Andrey ^a   Costea, Paul I ^a   Hedberg, Lilia ^a   Solnestam, Beata W ^a   Lundin, Sverker ^a   Hällman, Jimmie ^a   Lundberg, Emma ^a   Uhlén, Mathias ^a   Lundeberg, Joakim ^a  

^a ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PROTEOME; TRANSCRIPTOME;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; EXON; GENE DOSAGE; GENE EXPRESSION; GENE MUTATION; GENE REGULATORY NETWORK; GENE STRUCTURE; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GLIOBLASTOMA; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA;

EID: 84869000993     PISSN: None     EISSN: 1756994X     Source Type: Journal    
DOI: 10.1186/gm387     Document Type: Article

References (56)

1. Uhlen M, Oksvold P, Fagerberg L, Lundberg E, Jonasson K, Forsberg M, Zwahlen M, Kampf C, Wester K, Hober S, Wernerus H, Bjorling L, Ponten F. Towards a knowledge-based Human Protein Atlas. Nat Biotechnol 2010, 28:1248-1250. 10.1038/nbt1210-1248, 21139605.
2. Giard DJ, Aaronson SA, Todaro GJ, Arnstein P, Kersey JH, Dosik H, Parks WP. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst 1973, 51:1417-1423.
3. Westermark B, Ponten J, Hugosson R. Determinants for the establishment of permanent tissue culture lines from human gliomas. Acta Pathol Microbiol Scand A 1973, 81:791-805.
4. Ponten J, Saksela E. Two established in vitro cell lines from human mesenchymal tumours. Int J Cancer 1967, 2:434-447. 10.1002/ijc.2910020505, 6081590.
5. Ottaviani G, Jaffe N. The epidemiology of osteosarcoma. Cancer Treat Res 2009, 152:3-13. 10.1007/978-1-4419-0284-9_1, 20213383.
6. Ideker T, Sharan R. Protein networks in disease. Genome Res 2008, 18:644-652. 10.1101/gr.071852.107, 18381899.
7. Alexeyenko A, Lee W, Pernemalm M, Guegan J, Dessen P, Lazar V, Lehtio J, Pawitan Y. Network enrichment analysis: extension of gene-set enrichment analysis to gene networks. BMC Bioinformatics 2012, 13:226. 10.1186/1471-2105-13-226, 3505158, 22966941.
8. Reynolds CA, Hong MG, Eriksson UK, Blennow K, Wiklund F, Johansson B, Malmberg B, Berg S, Alexeyenko A, Gronberg H, Gatz M, Pedersen NL, Prince JA. Analysis of lipid pathway genes indicates association of sequence variation near SREBF1/TOM1L2/ATPAF2 with dementia risk. Hum Mol Genet 2010, 19:2068-2078. 10.1093/hmg/ddq079, 2860895, 20167577.
9. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674. 10.1016/j.cell.2011.02.013, 21376230.
10. Dutta B, Pusztai L, Qi Y, Andre F, Lazar V, Bianchini G, Ueno N, Agarwal R, Wang B, Shiang CY, Hortobagyi GN, Mills GB, Symmans WF, Balazsi G. A network-based, integrative study to identify core biological pathways that drive breast cancer clinical subtypes. Br J Cancer 2012, 106:1107-1116. 10.1038/bjc.2011.584, 22343619.
11. Alexeyenko A, Lee W, Pernemalm M, Guegan J, Dessen P, Lazar V, Lehtiö J, Pawitan P. Network enrichment analysis: extension of gene-set enrichment analysis to gene networks. BMC Bioinformatics 2012, 13:226. 10.1186/1471-2105-13-226, 3505158, 22966941.
12. De Smet R, Marchal K. Advantages and limitations of current network inference methods. Nat Rev Microbiol 2010, 8:717-729.
13. Alexeyenko A, Sonnhammer EL. Global networks of functional coupling in eukaryotes from comprehensive data integration. Genome Res 2009, 19:1107-1116. 10.1101/gr.087528.108, 2694487, 19246318.
14. Nibbe RK, Koyuturk M, Chance MR. An integrative -omics approach to identify functional sub-networks in human colorectal cancer. PLoS Comput Biol 2010, 6:e1000639. 10.1371/journal.pcbi.1000639, 2797084, 20090827.
15. Alexeyenko A, Wassenberg DM, Lobenhofer EK, Yen J, Linney E, Sonnhammer EL, Meyer JN. Dynamic zebrafish interactome reveals transcriptional mechanisms of dioxin toxicity. PLoS One 2010, 5:e10465. 10.1371/journal.pone.0010465, 2864754, 20463971.
16. WGS data. , http://www.ebi.ac.uk/ena/data/view/ERP001947
17. Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 2009, 25:1754-1760. 10.1093/bioinformatics/btp324, 2705234, 19451168.
18. Stranneheim H, Werne B, Sherwood E, Lundeberg J. Scalable transcriptome preparation for massive parallel sequencing. PLoS One 2011, 6:e21910. 10.1371/journal.pone.0021910, 3131396, 21760920.
19. Langmead B, Trapnell C, Pop M, Salzberg SL. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome biology 2009, 10:R25. 10.1186/gb-2009-10-3-r25, 2690996, 19261174.
20. RNA-Seq data. , http://www.ebi.ac.uk/ena/data/view/ERP001948
21. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 2008, 455:1061-1068. 10.1038/nature07385, 2671642, 18772890.
22. Reverter A, Chan EK. Combining partial correlation and an information theory approach to the reversed engineering of gene co-expression networks. Bioinformatics 2008, 24:2491-2497. 10.1093/bioinformatics/btn482, 18784117.
23. Kanehisa M, Goto S, Sato Y, Furumichi M, Tanabe M. KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Res 2011,
24. Ruepp A, Brauner B, Dunger-Kaltenbach I, Frishman G, Montrone C, Stransky M, Waegele B, Schmidt T, Doudieu ON, Stumpflen V, Mewes HW. CORUM: the comprehensive resource of mammalian protein complexes. Nucleic Acids Res 2008, 36:D646-650. 2238909, 17965090.
25. Maslov S, Sneppen K. Specificity and stability in topology of protein networks. Science 2002, 296:910-913. 10.1126/science.1065103, 11988575.
26. Bland JM, Altman DG. Statistics notes. The odds ratio. Bmj 2000, 320:1468. 10.1136/bmj.320.7247.1468, 1127651, 10827061.
27. AVADIS Data analysis was performed using Avadis® NGS software, Version 1.2.2, Build 146913. © Strand Scientific Intelligence, Inc., San Francisco, CA, USA. Avadis is a registered trademark of Strand Life Sciences Pvt. Ltd. In Book Data analysis was performed using Avadis® NGS software, Version 1.2.2, Build 146913. © Strand Scientific Intelligence, Inc., San Francisco, CA, USA. Avadis is a registered trademark of Strand Life Sciences Pvt Ltd (Editor ed.^eds.). City, AVADIS.
28. Korbel JO, Abyzov A, Mu XJ, Carriero N, Cayting P, Zhang Z, Snyder M, Gerstein MB. PEMer: a computational framework with simulation-based error models for inferring genomic structural variants from massive paired-end sequencing data. Genome biology 2009, 10:R23. 10.1186/gb-2009-10-2-r23, 2688268, 19236709.
29. Boeva V, Zinovyev A, Bleakley K, Vert JP, Janoueix-Lerosey I, Delattre O, Barillot E. Control-free calling of copy number alterations in deep-sequencing data using GC-content normalization. Bioinformatics 2011, 27:268-269. 10.1093/bioinformatics/btq635, 3018818, 21081509.
30. Gebow D, Miselis N, Liber HL. Homologous and nonhomologous recombination resulting in deletion: effects of p53 status, microhomology, and repetitive DNA length and orientation. Molecular and cellular biology 2000, 20:4028-4035. 10.1128/MCB.20.11.4028-4035.2000, 85773, 10805745.
31. Ritchie K, Seah C, Moulin J, Isaac C, Dick F, Berube NG. Loss of ATRX leads to chromosome cohesion and congression defects. The Journal of cell biology 2008, 180:315-324. 10.1083/jcb.200706083, 2213576, 18227278.
32. Lundberg E, Fagerberg L, Klevebring D, Matic I, Geiger T, Cox J, Algenas C, Lundeberg J, Mann M, Uhlen M. Defining the transcriptome and proteome in three functionally different human cell lines. Mol Syst Biol 2010, 6:450. 3018165, 21179022.
33. Schwanhausser B, Busse D, Li N, Dittmar G, Schuchhardt J, Wolf J, Chen W, Selbach M. Global quantification of mammalian gene expression control. Nature 2011, 473:337-342. 10.1038/nature10098, 21593866.
34. Lin J, Handschin C, Spiegelman BM. Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab 2005, 1:361-370. 10.1016/j.cmet.2005.05.004, 16054085.
35. Jucker M, Roebroek AJ, Mautner J, Koch K, Eick D, Diehl V, Van de Ven WJ, Tesch H. Expression of truncated transcripts of the proto-oncogene c-fps/fes in human lymphoma and lymphoid leukemia cell lines. Oncogene 1992, 7:943-952.
36. Zhang S, Chitu V, Stanley ER, Elliott BE, Greer PA. Fes tyrosine kinase expression in the tumor niche correlates with enhanced tumor growth, angiogenesis, circulating tumor cells, metastasis, and infiltrating macrophages. Cancer research 2011, 71:1465-1473. 10.1158/0008-5472.CAN-10-3757, 3041852, 21159660.
37. Geneimprint. , http://www.geneimprint.com
38. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR. A method and server for predicting damaging missense mutations. Nat Methods 2010, 7:248-249. 10.1038/nmeth0410-248, 2855889, 20354512.
39. McMurray HR, Sampson ER, Compitello G, Kinsey C, Newman L, Smith B, Chen SR, Klebanov L, Salzman P, Yakovlev A, Land H. Synergistic response to oncogenic mutations defines gene class critical to cancer phenotype. Nature 2008, 453:1112-1116. 10.1038/nature06973, 2613942, 18500333.
40. Liu F, Stanton JJ, Wu Z, Piwnica-Worms H. The human Myt1 kinase preferentially phosphorylates Cdc2 on threonine 14 and localizes to the endoplasmic reticulum and Golgi complex. Molecular and cellular biology 1997, 17:571-583. 231782, 9001210.
41. Booher RN, Holman PS, Fattaey A. Human Myt1 is a cell cycle-regulated kinase that inhibits Cdc2 but not Cdk2 activity. J Biol Chem 1997, 272:22300-22306. 10.1074/jbc.272.35.22300, 9268380.
42. Sigoillot FD, Berkowski JA, Sigoillot SM, Kotsis DH, Guy HI. Cell cycle-dependent regulation of pyrimidine biosynthesis. J Biol Chem 2003, 278:3403-3409.
43. Stratton MR, Campbell PJ, Futreal PA. The cancer genome. Nature 2009, 458:719-724. 10.1038/nature07943, 2821689, 19360079.
44. Ding L, Getz G, Wheeler DA, Mardis ER, McLellan MD, Cibulskis K, Sougnez C, Greulich H, Muzny DM, Morgan MB, Fulton L, Fulton RS, Zhang Q, Wendl MC, Lawrence MS, Larson DE, Chen K, Dooling DJ, Sabo A, Hawes AC, Shen H, Jhangiani SN, Lewis LR, Hall O, Zhu Y, Mathew T, Ren Y, Yao J, Scherer SE, Clerc K, Metcalf GA, et al. Somatic mutations affect key pathways in lung adenocarcinoma. Nature 2008, 455:1069-1075. 10.1038/nature07423, 2694412, 18948947.
45. Warburg O. On the origin of cancer cells. Science 1956, 123:309-314. 10.1126/science.123.3191.309, 13298683.
46. Kressler D, Schreiber SN, Knutti D, Kralli A. The PGC-1-related protein PERC is a selective coactivator of estrogen receptor alpha. J Biol Chem 2002, 277:13918-13925. 10.1074/jbc.M201134200, 11854298.
47. Lin J, Puigserver P, Donovan J, Tarr P, Spiegelman BM. Peroxisome proliferator-activated receptor gamma coactivator 1beta (PGC-1beta), a novel PGC-1-related transcription coactivator associated with host cell factor. J Biol Chem 2002, 277:1645-1648. 10.1074/jbc.C100631200, 11733490.
48. Puigserver P, Wu Z, Park CW, Graves R, Wright M, Spiegelman BM. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 1998, 92:829-839. 10.1016/S0092-8674(00)81410-5, 9529258.
49. MacDonald HR, Wevrick R. The necdin gene is deleted in Prader-Willi syndrome and is imprinted in human and mouse. Hum Mol Genet 1997, 6:1873-1878. 10.1093/hmg/6.11.1873, 9302265.
50. Ernst J, Kheradpour P, Mikkelsen TS, Shoresh N, Ward LD, Epstein CB, Zhang X, Wang L, Issner R, Coyne M, Ku M, Durham T, Kellis M, Bernstein BE. Mapping and analysis of chromatin state dynamics in nine human cell types. Nature 2011, 473:43-49. 10.1038/nature09906, 3088773, 21441907.
51. Maheswaran S, Englert C, Bennett P, Heinrich G, Haber DA. The WT1 gene product stabilizes p53 and inhibits p53-mediated apoptosis. Genes Dev 1995, 9:2143-2156. 10.1101/gad.9.17.2143, 7657166.
52. Taniura H, Matsumoto K, Yoshikawa K. Physical and functional interactions of neuronal growth suppressor necdin with p53. J Biol Chem 1999, 274:16242-16248. 10.1074/jbc.274.23.16242, 10347180.
53. Lu ZX, Jiang P, Cai JJ, Xing Y. Context-dependent robustness to 5' splice site polymorphisms in human populations. Hum Mol Genet 2011, 20:1084-1096. 10.1093/hmg/ddq553, 3043661, 21224255.
54. Mardis ER, Ding L, Dooling DJ, Larson DE, McLellan MD, Chen K, Koboldt DC, Fulton RS, Delehaunty KD, McGrath SD, Fulton LA, Locke DP, Magrini VJ, Abbott RM, Vickery TL, Reed JS, Robinson JS, Wylie T, Smith SM, Carmichael L, Eldred JM, Harris CC, Walker J, Peck JB, Du F, Dukes AF, Sanderson GE, Brummett AM, Clark E, McMichael JF, Meyer RJ, et al. Recurring mutations found by sequencing an acute myeloid leukemia genome. N Engl J Med 2009, 361:1058-1066. 10.1056/NEJMoa0903840, 3201812, 19657110.
55. Varela I, Tarpey P, Raine K, Huang D, Ong CK, Stephens P, Davies H, Jones D, Lin ML, Teague J, Bignell G, Butler A, Cho J, Dalgliesh GL, Galappaththige D, Greenman C, Hardy C, Jia M, Latimer C, Lau KW, Marshall J, McLaren S, Menzies A, Mudie L, Stebbings L, Largaespada DA, Wessels LF, Richard S, Kahnoski RJ, Anema J, Tuveson DA, et al. Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma. Nature 2011, 469:539-542. 10.1038/nature09639, 3030920, 21248752.
56. Barretina J, Caponigro G, Stransky N, Venkatesan K, Margolin AA, Kim S, Wilson CJ, Lehar J, Kryukov GV, Sonkin D, Reddy A, Liu M, Murray L, Berger MF, Monahan JE, Morais P, Meltzer J, Korejwa A, Jane-Valbuena J, Mapa FA, Thibault J, Bric-Furlong E, Raman P, Shipway A, Engels IH, Cheng J, Yu GK, Yu J, Aspesi P, de Silva M, Jagtap K, et al. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 2012, 483:603-607. 10.1038/nature11003, 3320027, 22460905.